Benchmark Botanics Inc. Engages The Howard Group to Direct Investor Communications and Capital Markets Support

Vancouver, British Columbia–(Newsfile Corp. – May 18, 2018) – Benchmark Botanics Inc. (CSE: BBT) (OTC Pink: BHHKF) (FSE: BBW) (the “Company” or “Benchmark“) is pleased to announce it has engaged The Howard Group as its capital markets communications advisor and will be responsible for directing both traditional and online communications initiatives, targeting the international investor community.

The Agreement is for one year term effective May 15, 2018.  The remuneration payable to The Howard Group will be $7,500 per month plus GST.  In addition, The Howard Group has been granted one million options, 750,000 of which will vest over the following eighteen months. These options will have a three-year term and an exercise price equal to the five day moving average trading price of $1.16. The Agreement and options grant are subject to the approval of the Canadian Securities Exchange.

Zhang Johnson, CEO of Benchmark stated: “This is a great step towards keeping close communication with the Canadian and International capital markets.”

Since 1988, The Howard Group has provided comprehensive investor outreach and capital markets programs, financing assistance, business development solutions and strategic planning to public companies. To learn more about The Howard Group, visit: www.howardgroupinc.com.

In addition, The Howard Group Inc. will be providing an ongoing commentary on Benchmark’s activities through its “Insight blog.”  Interested parties are encouraged to subscribe to the commentary feed: https://howardgroupinc.com/howard-group-blog/.

About Benchmark

Benchmark Botanics, Inc. is “Cannabis Redefined”

Benchmark is a publicly traded company based out of Vancouver, British Columbia that is positioned to provide financing, partnership and acquisition opportunities to licensed producers and ancillary businesses within the global cannabis industry.

In November 2017, the Company acquired its first subsidiary, Potanicals Green Growers Inc. Operating in Peachland, B.C., Potanicals Green Growers possesses a Health Canada license to cultivate cannabis and is an Access to Cannabis for Medical Purposes (ACMPR) Licensed Producer. In its first phase of operations, Potanicals is currently cultivating its 12,700 square foot PHASE I indoor production facility. Massive expansion plans are already under way to expand to approximately 1.9 million square feet of cultivation space.

For Further Information Contact:

Investor Relations
Benchmark Botanics, Inc.
Email: invest@bbtinc.ca
Tel: 1-888-221-0915
www.benchmarkbotanics.com

Dave Burwell
Vice President
The Howard Group Inc.
Email: dave@howardgroupinc.com
Tel: 403.221-9015
Toll Free: 1-888-221-0915

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this release.

Forward-Looking Statements

This news release contains forward-looking statements pertaining to various risks and uncertainties regarding future events. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Such forward-looking information can include without limitation statements based on current expectations involving a number of risks and uncertainties and are not guarantees of future performance of the Company Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. This news release includes forward-looking statements with respect to the business and future objectives of the Company. There are numerous risks and uncertainties that could cause actual results and the Company’s plans and objectives to differ materially from those expressed in the forward-looking information, including related to: (i) the facility and Potanicals’ operations; (ii) adverse market conditions; (iii) the ability of the Company to complete financings in the future; (iv) dependence on suppliers and skilled labour; (v) government regulation and compliance with the ACMPR; (vi) managing and maintaining growth; (vii) unfavourable publicity or consumer perception litigation; and (viii) competition. The Company is not currently producing medical marijuana. There is a risk that Potanicals’ Producer’s License will not be amended to permit the Company to sell medical marijuana produced at its facility. Actual results could differ materially from those currently anticipated due to a number of factors and risks including the risk factors discussed in this news release and in the Company’s disclosure documents, which can be found under the Company’s profile on www.sedar.com and on the CSE website. These statements speak only as of the date of this news release. Except as required by law, the Company does not intend to update these forward-looking statements.

Benchmark Botanics to Speak at SGS Canada’s National Roadshow, Coinciding with Its Silver Sponsorship of the 2018 LIFT MJ Expo (Booth 925)

Vancouver, British Columbia–(Newsfile Corp. – May 22, 2018) – Benchmark Botanics Inc. (CSE: BBT) (OTC Pink: BHHKF) (FSE: BBW) (the “Company” or “Benchmark“) announces that its Chief Operating Officer will be presenting at the SGS Canada National Roadshow: Mitigate Risk and Build Your Cannabis Business in Toronto. This talk will happen on May 25th, 2018, coinciding with Benchmark’s silver level sponsorship of the LIFT MJ Conference taking place May 25-27, 2018. More details and registration link below.

Along with other expert speakers from SGS, Calum Hughes, the Chief Operating Officer of Benchmark, will present a real-life case study on becoming a Canadian Licensed Producer. He will outline the actions taken to adhere to both ACMPR application and cultivation guidelines, including Benchmark’s approach to GMP compliance.

Benchmark is also pleased to announce that they will be hosting a 20-foot by 30-foot booth at the LIFT MJ Conference. The Benchmark team will be available at booth 925. Benchmark is currently scheduling one-to-one meetings during the conference in their boardroom meeting room. Please reserve your spot by contacting Dave Burwell at dave@howardgroupinc.com.

Speaking Event Details

National Roadshow: Mitigate Risk and Build Your Cannabis Business
Friday, May 25, 2018
8 AM – 12 PM
InterContinental Toronto Centre Hotel, Niagara Room
225 Front Street West, Toronto, ON

Registration Deadline

Thursday, May 24, 2018 (*No cost & space is limited) — click here to register.

For more details on the conference agenda and other aspects of the conference including reservations, please visit www.sgs.ca/en/events/2018/05/cannabis-roadshow.

LIFT MJ Conference Details: Benchmark will be in Booth 925. https://liftexpo.ca/

About SGS Canada:

SGS is the world’s leading inspection, verification, testing and certification company. We are recognized as the global benchmark for quality and integrity. With more than 95,000 employees, we operate a network of more than 2,400 offices and laboratories around the world.

About Benchmark

Benchmark Botanics, Inc. is: “Cannabis Redefined”.

Benchmark is a publicly traded company based out of Vancouver, British Columbia that is positioned to provide financing, partnership and acquisition opportunities to licensed producers and ancillary businesses within the global cannabis industry.

In November 2017, the Company acquired its first subsidiary, Potanicals Green Growers Inc.

Operating in Peachland, B.C., Potanicals Green Growers possesses a Health Canada license to cultivate cannabis and is an Access to Cannabis for Medical Purposes (ACMPR) Licensed Producer. In its first phase of operations, Potanicals is currently cultivating its 12,700 square foot PHASE I indoor production facility. Benchmark is actively pursuing opportunities to expand its cultivation capacity.

For Further Information

Investor Relations
Benchmark Botanics, Inc.
Email: invest@bbtinc.ca
Tel: 1-888-221-0915
www.benchmarkbotanics.com

Dave Burwell
Vice President
The Howard Group Inc.
Email: dave@howardgroupinc.com
Tel: 403.221-9015
Toll Free: 1-888-221-0915

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this release.

Forward-Looking Statements

This news release contains forward-looking statements pertaining to various risks and uncertainties regarding future events. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Such forward-looking information can include without limitation statements based on current expectations involving a number of risks and uncertainties and are not guarantees of future performance of the Company Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. This news release includes forward-looking statements with respect to the business and future objectives of the Company. There are numerous risks and uncertainties that could cause actual results and the Company’s plans and objectives to differ materially from those expressed in the forward-looking information, including related to: (i) the facility and Potanicals’ operations; (ii) adverse market conditions; (iii) the ability of the Company to complete financings in the future; (iv) dependence on suppliers and skilled labour; (v) government regulation and compliance with the ACMPR; (vi) managing and maintaining growth; (vii) unfavourable publicity or consumer perception litigation; and (viii) competition. The Company is not currently producing medical marijuana. There is a risk that Potanicals’ Producer’s License will not be amended to permit the Company to sell medical marijuana produced at its facility. Actual results could differ materially from those currently anticipated due to a number of factors and risks including the risk factors discussed in this news release and in the Company’s disclosure documents, which can be found under the Company’s profile on www.sedar.com and on the CSE website. These statements speak only as of the date of this news release. Except as required by law, the Company does not intend to update these forward-looking statements.

BENCHMARK BOTANICS ANNOUNCES ACQUISITION OF LANDS FOR EXPANSION OF ITS MARIJUANA PRODUCTION FACILITY

Vancouver, British Columbia, Canada – December 22, 2017: Benchmark Botanics Inc. (CSE: BBT) (the “Company” or “Benchmark“) is pleased to announce that the Company has completed the acquisition of a 10 acre land parcel (the “Stowell Property“) contiguous to the Company’s property that together comprises, in the total, 20 acres of land on which the Company’s facility is located. The acquisition was completed for a purchase price of $1,000,000 paid in cash pursuant to a Contract of Purchase and Sale dated November 30, 2017 as amended on December 15, 2017 with Claude Clifford Stowell as vendor. Mr. Stowell is the Chief Operating Officer and a director of the Company and also the President and a director of Potanicals. Prior entering into the Contract of Purchase and Sale, Mr. Stowell had leased the Stowell Property to Potanicals, and Potanicals was given a right of first refusal to purchase the Stowell Property, as disclosed in greater detail in the Company’s Listing Statement dated November 2, 2017, which is filed on SEDAR.

The purchase and sale of the land parcel is a ‘related party transaction’ within the meaning of Multilateral Instrument Protection of Minority Security Holders in Special Transactions (“MI 61- 101“) because the vendor is directors of Benchmark and Potanicals. The Company relies upon the exemption in section 5.5(b) of MI 61-101 from the requirement to obtain a formal valuation of the land parcel because the Company’s common shares are listed on the Canadian Securities Exchange and are not listed or quoted on any of the stock exchanges or markets specified in section 5.5(b). The Company also relies on the exemption contained in section 5.7(1)(a) of MI 61-101 from the requirement to obtain minority shareholder approval of the acquisition of the land parcel because neither the fair market value of the land to be purchased nor the fair market value of the consideration paid by the Company for the land exceeded 25 per cent of the Company’s market capitalization.

About Benchmark

Benchmark, through its wholly-owned subsidiary Potanicals Green Growers Inc., is a licensed producer of medical cannabis under the Access to Cannabis for Medical Purposes Regulations (“ACMPR“). The Company operates a 12,700 square foot production facility in Peachland, British Columbia and is in the design stage of a Phase II expansion of an additional 50,000 square feet of growing area. The Company intends to utilize advanced cultivation methods in its cannabis facilities to address the significant opportunities in the medical marijuana market in Canada and overseas.

For more information about Benchmark, refer to the Form 2A Listing Statement available to the
public under the Company’s profile on SEDAR at www.sedar.com and the CSE website.

ON BEHALF OF THE BOARD OF
BENCHMARK BOTANICS INC.

/s/ “Ping (Johnson) Zhang”
Ping (Johnson) Zhang
Chief Executive Officer

For further information contact:
Robert Wilson
Vice President
416.604.7900

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this release.

Forward-Looking Statements

This news release contains forward-looking statements pertaining to various risks and uncertainties regarding future events. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Such forward-looking information can include without limitation statements based on current expectations involving a number of risks and uncertainties and are not guarantees of future performance of the Company Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. This news release includes forward-looking statements with respect to the business and future objectives of the Company. There are numerous risks and uncertainties that could cause actual results and the Company’s plans and objectives to differ materially from those expressed in the forward-looking information, including related to: (i) the facility and Potanicals’ operations; (ii) adverse market conditions; (iii) the ability of the Company to complete financings in the future; (iv) dependence on suppliers and skilled labour; (v) government regulation and compliance with the ACMPR; (vi) managing and maintaining growth; (vii) unfavourable publicity or consumer perception litigation; and (viii) competition. The Company is not currently producing medical marijuana. There is a risk that Potanicals’ Producer’s License will not be amended to permit the Company to sell medical marijuana produced at its facility. Actual results could differ materially from those currently anticipated due to a number of factors and risks including the risk factors discussed in this news release and in the Company’s disclosure documents, which can be found under the Company’s profile on www.sedar.com and on the CSE website. These statements speak only as of the date of this news release. Except as required by law, the Company does not intend to update these forward-looking statements.